PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes. (Q47726365)

5 February 2018

review article

1 reference

title

PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes. (English)

1 reference

5 February 2018

0 references

1 reference

3

1 reference

5 February 2018

Johan Auwerx

series ordinal

4

object named as

Auwerx J

1 reference

5 February 2018

Martin G

1

1 reference

5 February 2018

Schoonjans K

series ordinal

2

1 reference

5 February 2018

publication date

1 April 1998

1 reference

5 February 2018

published in

Atherosclerosis

1 reference

5 February 2018

volume

137 Suppl

1 reference

5 February 2018

page(s)

S75-80

1 reference

5 February 2018

Diabetes in identical twins. A study of 200 pairs

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Molecular physiology and genetics of NIDDM. Importance of metabolic staging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Is familial combined hyperlipidaemia a genetic disorder of adipose tissue?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

The adipocyte: storage depot or node on the energy information superhighway?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Adipogenesis and obesity: rounding out the big picture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Lipoprotein lipase: recent contributions from molecular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Movement of fatty acids, fatty acid analogues, and bile acids across phospholipid bilayers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Peroxisome proliterator-activated receptors, orphans with ligands and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Two cis-acting regulatory sequences in the peroxisome proliferator-responsive enhancer region of rat acyl-CoA oxidase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

The organization, promoter analysis, and expression of the human PPARgamma gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

The PPARalpha-leukotriene B4 pathway to inflammation control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Transcription, adipocyte differentiation, and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Insulin resistance--mechanisms, syndromes, and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Modulation of insulin activities by leptin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Mechanisms of fatty acid-induced inhibition of glucose uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Effect of fatty acids on glucose production and utilization in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Effects of fat on insulin-stimulated carbohydrate metabolism in normal men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Operation of Randle's cycle in patients with NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Mechanism of free fatty acid-induced insulin resistance in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

Effect of long chain triglyceride infusion on glucose metabolism in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900315-8

10.1016/S0021-9150(97)00315-8

7 January 2021

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9694545

1 reference

5 February 2018